Skip to main content

OncXerna Therapeutics

Waltham, United States

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

Mar 2022
Venture - Series Unknown

Top Investors

Korea Investment PartnersPanacea VentureKB InvestmentK2 HealthVenturesNan Fung Life Sciences

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about OncXerna Therapeutics

Who are OncXerna Therapeutics's investors?
OncXerna Therapeutics's investors include Korea Investment Partners, Panacea Venture, KB Investment, K2 HealthVentures, Nan Fung Life Sciences.
Where is OncXerna Therapeutics headquartered?
OncXerna Therapeutics is headquartered in Waltham, United States.
What does OncXerna Therapeutics do?
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
What stage is OncXerna Therapeutics at?
OncXerna Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"OncXerna Therapeutics — Funding & Investors." VCBacked, March 3, 2022, https://www.vcbacked.co/company/oncxerna-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2022). OncXerna Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/oncxerna-therapeutics
Wikipedia (cite web)
{{cite web |title=OncXerna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oncxerna-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .